Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 207

Similar articles for PubMed (Select 24998463)


High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.

Xie J, Wang Q, Wang Q, Yao H, Wen L, Ma L, Wu D, Chen S.

Cancer Genet. 2014 May;207(5):226-30. doi: 10.1016/j.cancergen.2014.05.003. Epub 2014 May 16.


The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution.

Waanders E, Scheijen B, van der Meer LT, van Reijmersdal SV, van Emst L, Kroeze Y, Sonneveld E, Hoogerbrugge PM, van Kessel AG, van Leeuwen FN, Kuiper RP.

PLoS Genet. 2012;8(2):e1002533. doi: 10.1371/journal.pgen.1002533. Epub 2012 Feb 16.


Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.

Balatzenko G, Guenova M, Kalinova I, Belcheva M, Hristozova H, Kaleva V.

Cancer Genet. 2013 Mar;206(3):97-101. doi: 10.1016/j.cancergen.2013.01.004. Epub 2013 Mar 13.


Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G.

Blood. 2009 Sep 3;114(10):2159-67. doi: 10.1182/blood-2008-08-173963. Epub 2009 Jul 9. Erratum in: Blood. 2010 Sep 23;116(12):2196.


Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.

Sindt A, Deau B, Brahim W, Staal A, Visanica S, Villarese P, Rault JP, Macintyre E, Delabesse E.

Genes Chromosomes Cancer. 2006 Jun;45(6):575-82.


Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.

Burmeister T, Gröger D, Kühn A, Hoelzer D, Thiel E, Reinhardt R.

DNA Repair (Amst). 2011 Nov 10;10(11):1131-7. doi: 10.1016/j.dnarep.2011.08.010. Epub 2011 Sep 22.


BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, Relling MV, Shurtleff SA, Downing JR.

Nature. 2008 May 1;453(7191):110-4. doi: 10.1038/nature06866. Epub 2008 Apr 13.


The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.

Iacobucci I, Lonetti A, Paoloni F, Papayannidis C, Ferrari A, Storlazzi CT, Vignetti M, Cilloni D, Messa F, Guadagnuolo V, Paolini S, Elia L, Messina M, Vitale A, Meloni G, Soverini S, Pane F, Baccarani M, Foà R, Martinelli G.

Haematologica. 2010 Oct;95(10):1683-90. doi: 10.3324/haematol.2009.020792. Epub 2010 Jun 9.


p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC.

Blood. 1996 Jun 15;87(12):5213-7.


Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).

De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J, Wlodarska I, Vandenberghe P, Hagemeijer A, Marynen P, Cools J.

Blood. 2005 Jun 15;105(12):4849-52. Epub 2005 Feb 15.


Identification of a novel fusion gene involving RUNX1 and the antisense strand of SV2B in a BCR-ABL1-positive acute leukemia.

Giguère A, Hébert J.

Genes Chromosomes Cancer. 2013 Dec;52(12):1114-22. doi: 10.1002/gcc.22105. Epub 2013 Oct 3.


Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

van der Veer A, Waanders E, Pieters R, Willemse ME, Van Reijmersdal SV, Russell LJ, Harrison CJ, Evans WE, van der Velden VH, Hoogerbrugge PM, Van Leeuwen F, Escherich G, Horstmann MA, Mohammadi Khankahdani L, Rizopoulos D, De Groot-Kruseman HA, Sonneveld E, Kuiper RP, Den Boer ML.

Blood. 2013 Oct 10;122(15):2622-9. doi: 10.1182/blood-2012-10-462358. Epub 2013 Aug 23.


Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.

Carranza C, Granados L, Morales O, Jo W, Villagran S, Tinti D, Villegas M, Antillón F, Torselli S, Silva G.

Cancer Genet. 2013 Jun;206(6):227-32. doi: 10.1016/j.cancergen.2013.05.017. Epub 2013 Jul 13.


Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.

Loncarevic IF, Römer J, Starke H, Heller A, Bleck C, Ziegler M, Fiedler W, Liehr T, Clement JH, Claussen U.

Genes Chromosomes Cancer. 2002 Jun;34(2):193-200.


Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.

Anastasi J, Feng J, Dickstein JI, Le Beau MM, Rubin CM, Larson RA, Rowley JD, Vardiman JW.

Leukemia. 1996 May;10(5):795-802.


[Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].

Yan LZ, Chen SN, Ping NN, Wang QR, Liu H, Ding ZX, Zhu MQ, Liang JY, Liu DD, Cen JN, Pan JL, Qiu HY, Sun AN, Wu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1116-20. doi: 10.7534/j.issn.1009-2137.2013.05.006. Chinese.


TEL/AML1 fusion gene resulting from a cryptic t(12;21) is uncommon in adult patients with B-cell lineage ALL and CML lymphoblastic transformation.

Hoshino K, Asou N, Suzushima H, Osato M, Yamasaki H, Okubo T, Nishimura S, Kiyokawa T, Kawano F, Takatsuki K.

Int J Hematol. 1997 Aug;66(2):213-8.


A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.

Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.

Genes Chromosomes Cancer. 2003 Jul;37(3):291-9.


RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.

Roche-Lestienne C, Deluche L, Corm S, Tigaud I, Joha S, Philippe N, Geffroy S, Laï JL, Nicolini FE, Preudhomme C; Fi-LMC group.

Blood. 2008 Apr 1;111(7):3735-41. doi: 10.1182/blood-2007-07-102533. Epub 2008 Jan 17.


[Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].

Zhu YL, Zhang Y, Zhu P, Yang Y, Du JW, Liu J.

Beijing Da Xue Xue Bao. 2005 Jun 18;37(3):236-9. Chinese.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk